<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/diabetes-gray-matter-loss-and-cognition-in-the-setting-of-parkinson-disease/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/diabetes-gray-matter-loss-and-cognition-in-the-setting-of-parkinson-disease/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2016-04-30T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2016-04-30T17:00:00+00:00","description":"Rationale and Objectives","headline":"Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/diabetes-gray-matter-loss-and-cognition-in-the-setting-of-parkinson-disease/"},"url":"https://clinicaltree.github.io/posts/diabetes-gray-matter-loss-and-cognition-in-the-setting-of-parkinson-disease/"}</script><title>Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1462035600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 30, 2016 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">M. Petrou</a> </em>, <em> <a href="">C. Davatzikos</a> </em>, <em> <a href="">M. Hsieh</a> </em>, <em> <a href="">B.R. Foerster</a> </em>, <em> <a href="">R.L. Albin</a> </em>, <em> <a href="">V. Kotagal</a> </em>, <em> <a href="">M.L. Müller</a> </em>, <em> <a href="">R.A. Koeppe</a> </em>, <em> <a href="">W.H. Herman</a> </em>, <em> <a href="">K.A. Frey</a> </em>, <em> <a href="">N.I. Bohnen</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1838 words"> <em>10 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Parkinson disease (PD) is a progressive neurodegenerative disorder affecting motor and cognitive functions. Prior studies showed that patients with PD and diabetes (DM) demonstrate worse clinical outcomes compared to nondiabetic subjects with PD. Our study aimed at defining the relationship between DM, gray matter volume, and cognition in patients with PD.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>This study included 36 subjects with PD (12 with DM, 24 without DM, mean age = 66). Subjects underwent high-resolution T1-weighted brain magnetic resonance imaging, [ 11 C]dihydrotetrabenazine positron emission tomography imaging to quantify nigrostriatal dopaminergic denervation, clinical, and cognitive assessments. Magnetic resonance images were postprocessed to determine total and lobar cortical gray matter volumes. Cognitive testing scores were converted to z-scores for specific cognitive domains and a composite global cognitive z-score based on normative data computed. Analysis of covariance, accounting for effects of age, gender, intracranial volume, and striatal [ 11 C]dihydrotetrabenazine binding, was used to test the relationship between DM and gray matter volumes.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Impact of DM on total gray matter volume was significant ( <em>P</em> = 0.02). Post hoc analyses of lobar cortical gray matter volumes revealed that DM was more selectively associated with lower gray matter volumes in the frontal regions ( <em>P</em> = 0.01). Cognitive post hoc analyses showed that interaction of total gray matter volume and DM status was significantly associated with composite ( <em>P</em> = 0.007), executive ( <em>P</em> = 0.02), and visuospatial domain cognitive z-scores ( <em>P</em> = 0.005). These associations were also significant for the frontal cortical gray matter.</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>DM may exacerbate brain atrophy and cognitive functions in PD with greater vulnerability in the frontal lobes. Given the high prevalence of DM in the elderly, delineating its effects on patient outcomes in the PD population is of importance.</p><h2 id="introduction"><span class="mr-2">Introduction</span><a href="#introduction" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Numerous epidemiologic studies show increased risk of dementia in diabetic subjects compared to nondiabetic individuals. A recent meta-analysis of 16 prior studies (5706 people with diabetes [DM] and 36,191 without DM) estimated a relative risk of 1.5 for clinically defined Alzheimer disease and 2.5 for vascular dementia in diabetic persons compared to nondiabetic individuals . Furthermore, a recent prospective study showed that elevated blood glucose in the absence of DM increases the risk of dementia .</p><p>In patients with Parkinson disease (PD), associations between DM and more severe motor symptoms and increased levodopa requirements are described . More specifically, DM in the setting of PD is associated with more severe postural instability and gait difficulty features of PD .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="subjects-and-clinical-test-battery"><span class="mr-2">Subjects and Clinical Test Battery</span><a href="#subjects-and-clinical-test-battery" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Clinical Characteristics of Study Subjects</p><p>PD without DM ( <em>N</em> = 24, M/F = 21/3) PD with DM ( <em>N</em> = 12, M/F = 10/2) Group Comparison Age (y) 66.8 (5.3) 66.0 (5.2)<em>P</em> = 0.7 Hoehn-Yahr stage 2.3 (0.6) 2.6 (0.9)<em>P</em> = 0.3 PD duration (y) 6.2 (4.4) 5.6 (4.6)<em>P</em> = 0.7 Education (y) 15.1 (2.9) 14.3 (2.8)<em>P</em> = 0.5 MoCa 25.6 (2.3) 25.3 (2.2)<em>P</em> = 0.7 Sex (% male) 86.3 83.3<em>P</em> = 0.8</p><p>DM, diabetes; PD, Parkinson disease.</p><p>Mean values and standard deviations for age (in years), Hoehn-Yahr stage, disease duration (in years), and years of education, as well as Montreal Cognitive Assessment (MoCA) scores are provided.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="cognitive-assessment"><span class="mr-2">Cognitive Assessment</span><a href="#cognitive-assessment" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-techniques"><span class="mr-2">Imaging Techniques</span><a href="#imaging-techniques" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="dtbz-pet-imaging"><span class="mr-2">DTBZ PET Imaging</span><a href="#dtbz-pet-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="pet-imaging-analysis"><span class="mr-2">PET Imaging Analysis</span><a href="#pet-imaging-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mri"><span class="mr-2">MRI</span><a href="#mri" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mri-analysis"><span class="mr-2">MRI Analysis</span><a href="#mri-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="standard-protocol-approvals-registrations-and-patient-consents"><span class="mr-2">Standard Protocol Approvals, Registrations, and Patient Consents</span><a href="#standard-protocol-approvals-registrations-and-patient-consents" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="relationship-between-gray-matter-volumes-and-presence-of-dm-in-pd"><span class="mr-2">Relationship Between Gray Matter Volumes and Presence of DM in PD</span><a href="#relationship-between-gray-matter-volumes-and-presence-of-dm-in-pd" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Effects of Diabetes on Lobar Gray Matter Volumes</p><p>PD without DM PD with DM Striatal DTBZ Age Sex ICV DM Overall Model Total GM 666.8 (58.9) 611.4 (38.3) (−8.3%) 2.50 (0.13) 15.9 (0.0004) 0.88 (0.35) 69.2 (&lt;0.0001) 5.96 (0.02) 32.7 (&lt;0.001)<em>Post hoc lobar analyses</em> Frontal GM 185.8 (19.6) 165.7 (13.6) (−10.8%) 1.14 (0.30) 9.67 (0.004) 0.09 (0.76) 31.05 (&lt;0.0001) 6.65 (0.015) 16.61 (&lt;0.001) Parietal GM 90.5 (9.9) 83.8 (5.0) (−7.4%) 1.74 (0.20) 0.94 (0.34) 1.13 (0.30) 32.12 (&lt;0.0001) 0.32 (0.58) 11.74 (&lt;0.001) Temporal GM 110.2 (11.6) 102.2 (7.9) (−7.2%) 1.74 (0.20) 15.35 (0.0005) 0.17 (0.68) 0.05 (&lt;0.0001) 2.81 (0.10) 13.16 (&lt;0.001) Occipital GM 75.6 (8.3) 69.6 (6.0) (−7.9%) 5.0 (0.03) 1.03 (0.36) 5.65 (0.03) 51.2 (&lt;0.0001) 0.86 (0.36) 21.2 (&lt;0.0001)</p><p>ANCOVA, analysis of covariance; DM, diabetes; DTBZ, [ 11 C]dihydrotetrabenazine; GM, gray matter; ICV, intracranial volume; PD, Parkinson disease; SD, standard deviation.</p><p>Mean (±SD) total and lobar gray matter volumes in the subjects with PD with and without diabetes. ANCOVA F values (with levels of significance) for the overall models as well as for striatal DTBZ distribution volume ratio (DVR), age, sex, intracranial volume, and diabetes group covariates are also presented. Holm-Bonferroni correction for multiple comparisons was applied for post hoc lobar gray matter analyses.</p><p>Table 3</p><p>Associations Between Diabetes, Gray Matter Volumes, and Cognitive Scores</p><p>Striatal DTBZ Age Sex ICV Total Gray Matter Volume × DM Overall Model Composite cognitive z-score 3.91 (0.06) 0.07 (0.7) 5.19 (0.03) 4.48 (0.04) 5.26 (0.01) 4.10 (0.0047)<em>Post hoc cognitive domain analyses</em> Executive z-score 1.99 (0.17) 0.33 (0.57) 5.13 (0.03) 4.47 (0.04) 4.30 (0.02) 3.79 (0.007) Visuospatial z-score 0.23 (0.63) 2.12 (0.15) 2.54 (0.12) 5.08 (0.03) 6.40 (0.005) 3.10 (0.02) Attention z-score 1.45 (0.24) 0.37 (0.54) 1.53 (0.22) 0.89 (0.35) 1.68 (0.20) 1.55 (0.20) Memory z-score 4.67 (0.04) 0 (0.99) 2.58 (0.12) 2.93 (0.10) 2.16 (0.13) 2.59 (0.04)</p><p>ANCOVA, analysis of covariance; DM, diabetes; DTBZ, [ 11 C]dihydrotetrabenazine; DVR, distribution volume ratio; ICV, intracranial volume.</p><p>Results for ANCOVA analysis with cognitive z-scores as the outcome variables and explanatory variables of total gray matter volume × DM status interaction, striatal DTBZ DVR, age, sex, and ICV. F values (with levels of significance) for the overall models as well as individual parameters and associated <em>P</em> values are presented. Holm-Bonferroni correction for multiple comparisons was applied for post hoc cognitive domain score analyses.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="post-hoc-analysis-on-the-relationship-between-cognitive-test-performance-and-gray-matter-lossregional-cortical-atrophy---table3--"><span class="mr-2">Post Hoc Analysis on the Relationship Between Cognitive Test Performance and Gray Matter Loss/Regional Cortical Atrophy ( Table 3 )</span><a href="#post-hoc-analysis-on-the-relationship-between-cognitive-test-performance-and-gray-matter-lossregional-cortical-atrophy---table3--" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Cheng G., Huang C., Deng H., et. al.: Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 2012; 42: pp. 484-491.</p><li><p>2. Crane P.K., Walker R., Larson E.B.: Glucose levels and risk of dementia. N Engl J Med 2013; 369: pp. 1863-1864.</p><li><p>3. Cereda E., Barichella M., Cassani E., et. al.: Clinical features of Parkinson disease when onset of diabetes came first: a case-control study. Neurology 2012; 78: pp. 1507-1511.</p><li><p>4. Kotagal V., Albin R.L., Muller M.L., et. al.: Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism Relat Disord 2013; 19: pp. 522-526.</p><li><p>5. Alves G., Larsen J.P., Emre M., et. al.: Changes in motor subtype and risk for incident dementia in Parkinson’s disease. Mov Disord 2006; 21: pp. 1123-1130.</p><li><p>6. Post B., Merkus M.P., de Haan R.J., et. al.: Prognostic factors for the progression of Parkinson’s disease: a systematic review. Mov Disord 2007; 22: pp. 1839-1851. quiz 1988</p><li><p>7. Giuntini M., Baldacci F., Del Prete E., et. al.: Diabetes is associated with postural and cognitive domains in Parkinson’s disease. Results from a single-center study. Parkinsonism Relat Disord 2014; 20: pp. 671-672.</p><li><p>8. Bohnen N.I., Kotagal V., Muller M.L., et. al.: Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease. Parkinsonism Relat Disord 2014; 20: pp. 1394-1398.</p><li><p>9. Erus G., Battapady H., Zhang T., et. al.: Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose. Diabetes Care 2015; 38: pp. 97-104.</p><li><p>10. Moran C., Phan T.G., Chen J., et. al.: Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 2013; 36: pp. 4036-4042.</p><li><p>11. Biessels G.J., De Leeuw F.E., Lindeboom J., et. al.: Increased cortical atrophy in patients with Alzheimer’s disease and type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry 2006; 77: pp. 304-307.</p><li><p>12. Falvey C.M., Rosano C., Simonsick E.M., et. al.: Macro- and microstructural magnetic resonance imaging indices associated with diabetes among community-dwelling older adults. Diabetes Care 2013; 36: pp. 677-682.</p><li><p>13. Hughes A.J., Daniel S.E., Kilford L., et. al.: Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: pp. 181-184.</p><li><p>14. Nasreddine Z.S., Phillips N.A., Bedirian V., et. al.: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: pp. 695-699.</p><li><p>15. Jewett D.M., Kilbourn M.R., Lee L.C.: A simple synthesis of [11C]dihydrotetrabenazine (DTBZ). Nucl Med Biol 1997; 24: pp. 197-199.</p><li><p>16. Logan J., Fowler J.S., Volkow N.D., et. al.: Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996; 16: pp. 834-840.</p><li><p>17. Ou Y., Sotiras A., Paragios N., et. al.: DRAMMS: deformable registration via attribute matching and mutual-saliency weighting. Med Image Anal 2011; 15: pp. 622-639.</p><li><p>18. Hanganu A., Bedetti C., Degroot C., et. al.: Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson’s disease longitudinally. Brain 2014; 137: pp. 1120-1129.</p><li><p>19. Weintraub D., Doshi J., Koka D., et. al.: Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 2011; 68: pp. 1562-1568.</p><li><p>20. Jellinger K.A.: Prevalence of cerebrovascular lesions in Parkinson’s disease. A postmortem study. Acta Neuropathol 2003; 105: pp. 415-419.</p><li><p>21. Crivello F., Tzourio-Mazoyer N., Tzourio C., et. al.: Longitudinal assessment of global and regional rate of grey matter atrophy in 1,172 healthy older adults: modulation by sex and age. PLoS ONE 2014; 9: pp. e114478.</p><li><p>22. Centers for Disease Control and Prevention : National Diabetes Fact Sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011.2011.U.S. Department of Health and Human Services, Centers for Disease Control and PreventionAtlanta, GA</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-23/'>Volume 23</a>, <a href='/categories/issue-5/'>Issue 5</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Diabetes,%20Gray%20Matter%20Loss,%20and%20Cognition%20in%20the%20Setting%20of%20Parkinson%20Disease%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdiabetes-gray-matter-loss-and-cognition-in-the-setting-of-parkinson-disease%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Diabetes,%20Gray%20Matter%20Loss,%20and%20Cognition%20in%20the%20Setting%20of%20Parkinson%20Disease%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdiabetes-gray-matter-loss-and-cognition-in-the-setting-of-parkinson-disease%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdiabetes-gray-matter-loss-and-cognition-in-the-setting-of-parkinson-disease%2F&text=Diabetes,%20Gray%20Matter%20Loss,%20and%20Cognition%20in%20the%20Setting%20of%20Parkinson%20Disease%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/assessing-medical-student-knowledge-of-imaging-modality-selection-before-and-after-a-general-radiolo/"><div class="card-body"> <em class="small" data-ts="1462035600" data-df="ll" > Apr 30, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Assessing Medical Student Knowledge of Imaging Modality Selection Before and After a General Radiology Elective A Comparison of MS-IIs, MS-IIIs, and MS-IVs</h3><div class="text-muted small"><p> Rationale and Objectives Correct selection of imaging tests is essential for clinicians but until recently has been largely neglected in medical education. How and when students acquire such non-i...</p></div></div></a></div><div class="card"> <a href="/posts/comparative-effectiveness-of-imaging-modalities-for-the-diagnosis-of-intestinal-obstruction-in-neona/"><div class="card-body"> <em class="small" data-ts="1462035600" data-df="ll" > Apr 30, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Comparative Effectiveness of Imaging Modalities for the Diagnosis of Intestinal Obstruction in Neonates and Infants</h3><div class="text-muted small"><p> Rationale and Objectives The purpose of this study was to critically appraise and compare the diagnostic performance of imaging modalities that are used for the diagnosis of upper and lower gastro...</p></div></div></a></div><div class="card"> <a href="/posts/comparison-of-diffusion-tensor-imaging-and-magnetic-resonance-perfusion-imaging-in-differentiating-r/"><div class="card-body"> <em class="small" data-ts="1462035600" data-df="ll" > Apr 30, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis</h3><div class="text-muted small"><p> Rationale and Objectives To compare differences in diffusion tensor imaging (DTI) and dynamic susceptibility-weighted contrast-enhanced (DSC) magnetic resonance (MR) perfusion imaging characterist...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/comparison-of-measured-and-estimated-ct-organ-doses-for-modulated-and-fixed-tube-current/" class="btn btn-outline-primary" prompt="Older"><p>Comparison of Measured and Estimated CT Organ Doses for Modulated and Fixed Tube Current</p></a> <a href="/posts/dual-energy-ct-aortography-with-50-reduced-iodine-dose-versus-single-energy-ct-aortography-with-sta/" class="btn btn-outline-primary" prompt="Newer"><p>Dual-energy CT Aortography with 50% Reduced Iodine Dose Versus Single-energy CT Aortography with Standard Iodine Dose</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
